CAUSAL GENES AND PATHOGENIC MECHANISMS UNDERLYING GASTROINTESTINAL DISEASES
Professor Mauro D’Amato
Professor of Medical Genetics, Department of Medicine and Surgery,
LUM University in Casamassima, Italy &
Ikerbasque Research Professor and Head of the Gastrointestinal Genetics Lab
CIC bioGUNE, Derio, Spain
RESEARCHER PROFILE
Filmed online | January 2025
Mauro D’Amato is Professor of Medical Genetics at the Department of Medicine and Surgery at LUM University in Casamassima – Italy, and Ikerbasque Research Professor and Head of the Gastrointestinal Genetics Lab in CIC bioGUNE, Derio – Spain. His career has developed through an important international trajectory, holding research and academic positions at several institutions including the Wellcome Trust Center for Human Genetics in Oxford – UK, the Karolinska Institutet in Stockholm – Sweden, Biodonostia HRI in San Sebastian – Spain and Monash University in Melbourne – Australia.
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
He is also the coordinator of the bellygenes initiative on the genetics of IBS, and biobank-scale research from his lab contributes to multiple scientific consortia and collaborative networks studying the genetic makeup of millions of people across EU, USA and Australasia.
Professor D’Amato has an H-index of 74, has edited 2 books and published extensively in the field of human genetics and gastrointestinal disease; he provides expert feedback to international journals and research funding agencies, and has supervised more than 40 PhD students and postdocs.
https://orcid.org/0000-0003-2743-5197
-
Hormone receptor positive breast cancer and therapy resistance
Prof Elgene Lim is a medical oncologist at St Vincent’s Hospital and Head of the Connie Johnson Breast Cancer Research Lab at the Garvan Institute. Following his PhD at the Walter & Eliza Hall Institute where he identified the aberrant cells in carriers of the BRCA1 mutant gene, a hereditary breast cancer syndrome as the culprit cells giving rise to breast cancer, he furthered his research and clinical training at the Dana-Farber Cancer Institute and Harvard Medical School. He was awarded the National Breast Cancer Foundation Practitioner Fellowship in 2014 and returned from Boston to Australia. In 2017, he was awarded the inaugural National Breast Cancer Foundation Endowed Chair, and subsequently appointed the Principal Cancer Theme Lead at UNSW.
-
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
